Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $16.2650 (-1.42%) ($16.2650 - $16.2650) on Tue. Jul. 6, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.74% (three month average) | RSI | 58 | Latest Price | $16.2650(-1.42%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.8% a day on average for past five trading days. | Weekly Trend | BCRX declines -0.5% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(45%) IBB(40%) IWO(37%) ARKK(36%) ARKG(35%) | Factors Impacting BCRX price | BCRX will decline at least -2.37% in a week (0% probabilities). VIXM(-23%) UUP(-14%) VXX(-7%) TBT(-2%) IGOV(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.37% (StdDev 4.74%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $10.11(-37.84%) | Resistance Level | $16.43 | 5 Day Moving Average | $16.07(1.21%) | 10 Day Moving Average | $16.36(-0.58%) | 20 Day Moving Average | $16.43(-1%) | To recent high | -5.6% | To recent low | 71.3% | Market Cap | $2.87b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |